
European Journal of Medicinal Chemistry p. 399 - 420 (1998)
Update date:2022-08-05
Topics:
Leonardi, Amedeo
Motta, Gianni
Pennini, Renzo
Testa, Rodolfo
Sironi, Giorgio
Catto, Alberto
Cerri, Alberto
Zappa, Marco
Bianchi, Giorgio
Nardi, Dante
A series of asymmetric 4-aryl-1,4-dihydropyridine-3,5-dicarboxylates characterized by the presence of a 3,3-diphenylpropylamino moiety in one of the ester groups were synthesized. They exhibited remarkable antihypertensive activity in spontaneously hypertensive rats as well as affinity for the 1,4- dihydropyridines binding site labelled by 3H-nitrendipine in the calcium channel. Introduction of this bulky and lipophilic amine confers to the whole series an elevated level of antihypertensive activity and a long duration of action, a structure-dependent modulation of the activity being found only in the subset characterized by the presence of a branched propylene bridge between the ester and the amino groups. The presence of the amino group is essential for oral activity. Out of this series, compound 9u (Rec 15/2375- lercanidipine) was selected for clinical development and obtained marketing authorization as an antihypertensive in several countries.
View MoreContact:+86-25-52346955
Address:199,JIANYE ROAD,NANJING,CHINA
Changzhou BaoKang Pharmaceutical & Chemical Co., Ltd
Contact:(86) 519-88782201 88784080 88785278
Address:Henglin town, changzhou,Jiangsu
Xi'an Unique Electronic and Chemical Co., Ltd.
Contact:+86-029-88238008
Address:1703# B BUILDING WEST ELECTRONIC ZONE, XI'AN, CHINA
NANCHANG QINZHI SCI&TEC.CO.,LTD(expird)
Contact:+86-13687004106
Address:Hero South Road,Hero Zone,Nanchang,Jiangxi,China
Contact:+86-371-86058576
Address:NO.32, Jingsan Road, Zhengzhou, China
Doi:10.1007/s11178-006-0034-8
(2005)Doi:10.1021/jm00117a013
(1988)Doi:10.1016/0022-328X(85)80069-3
(1985)Doi:10.1016/j.bmc.2007.11.060
(2008)Doi:10.1016/S0040-4020(01)96638-4
(1985)Doi:10.1021/jm901771h
(2010)